STOCK TITAN

Director Brian P. McKeon adds 10,000 DENTSPLY SIRONA (XRAY) shares via trust purchase

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Brian P. McKeon reported an open-market purchase of the company’s common stock. On June 12, 2026, a trust associated with him bought 10,000 shares at $10.12 per share, held as indirect ownership. A separate entry shows he directly holds 28,887 common shares following the reported transactions.

Positive

  • None.

Negative

  • None.
Insider MCKEON BRIAN P
Role null
Bought 10,000 shs ($101K)
Type Security Shares Price Value
Purchase Common Stock 10,000 $10.12 $101K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 10,000 shares (Indirect, By a Trust); Common Stock — 28,887 shares (Direct, null)
Footnotes (1)
Shares purchased 10,000 shares Open-market purchase on June 12, 2026
Purchase price $10.12 per share Common Stock, open-market transaction
Indirect shares after transaction 10,000 shares Held by a trust associated with the director
Direct shares held 28,887 shares Direct common stock holding following reported transactions
Net share change 10,000 shares Net-buy according to transaction summary
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
indirect ownership financial
"ownership_type": "indirect""
By a Trust financial
"nature_of_ownership": "By a Trust""
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCKEON BRIAN P

(Last)(First)(Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NORTH CAROLINA 28277

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/12/2026P10,000A$10.1210,000IBy a Trust
Common Stock28,887D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Jessica Nielsen Causey, Attorney-In-Fact for Brian P. McKeon06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) disclose for Brian P. McKeon?

DENTSPLY SIRONA disclosed that director Brian P. McKeon was associated with an open-market purchase of 10,000 shares of common stock. The trade was reported on June 12, 2026 and was executed at a price of $10.12 per share.

How many DENTSPLY SIRONA (XRAY) shares did the trust buy and at what price?

A trust associated with director Brian P. McKeon bought 10,000 shares of DENTSPLY SIRONA common stock. The shares were acquired in an open-market purchase at a reported price of $10.12 per share on June 12, 2026.

Is Brian P. McKeon’s 10,000-share DENTSPLY SIRONA (XRAY) purchase direct or indirect?

The 10,000-share purchase of DENTSPLY SIRONA common stock is reported as indirect ownership. The filing states the shares are held “By a Trust,” indicating they are owned through a trust rather than directly by Brian P. McKeon.

How many DENTSPLY SIRONA (XRAY) shares does Brian P. McKeon hold directly after the filing?

The Form 4 shows a holding entry indicating Brian P. McKeon directly owns 28,887 shares of DENTSPLY SIRONA common stock. This figure is reported as his direct ownership following the transactions listed in the filing.

What is the net share effect of Brian P. McKeon’s latest DENTSPLY SIRONA (XRAY) Form 4?

The transaction summary indicates a net purchase of 10,000 DENTSPLY SIRONA shares. There was one open-market buy of 10,000 shares, no reported sales, and the filing categorizes the overall direction as a net-buy position change.